Cost Plus Drugs and eNavvi Enhance Prescription Access
eNavvi, Inc., a leader in the prescription marketplace, and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) have announced a strategic collaboration that allows physicians to prescribe medications directly through eNavvi's digital prescription platform to over 7,000 independent pharmacies and major national grocery pharmacy chains. This partnership aims to streamline the prescribing process, enhance convenience, and improve prescription price transparency for patients across the country. With this integration, physicians can leverage eNavvi's platform to compare medication prices in real-time and easily prescribe with just a few clicks. Patients benefit from the ability to pick up their prescriptions from local pharmacies, providing greater convenience and quicker access, particularly for time-sensitive medications.Cost Plus Drugs and eNavvi Enhance Prescription Access